Grace M Egeland, Rolv Skjaerven, Lorentz M Irgens Women with gestational diabetes are at increased risk of non-insulin dependent diabetes and their babies are at increased risk of adverse perinatal outcomes.
Identifying risk factors for gestational diabetes may improve screening programmes. As low birth weight has been related to non-insulin dependent diabetes in elderly populations, 3 we decided to investigate whether women's characteristics at birth could predict their subsequent risk of gestational diabetes.
Subjects, methods, and results
We used linked generation data from the medical birth registry of Norway to study all women born in 1967-84 who had given birth between 1988 and 1998. The registry is a compulsory reporting system and files used for analysis are anonymised. Although there were 141 107 women in the cohort, we excluded 2393 who were not singletons.
We compared the birth characteristics of women with and without self reported gestational diabetes in one or more pregnancies. Data were analysed in relation to categories of birth weight; the ponderal index at birth (m/g 3 ×100); gestational age (excluding women who were considered misclassified) 4 ; weight for gestational age; and whether the woman had a mother whose pregnancy had been complicated by diabetes (any type), pre-eclampsia, eclampsia, placental abruption, or hypertension. We also considered diabetes in relation to the women's age and parity and their mothers' age and parity when they were born. We calculated odds ratios obtained from logistic regression analyses in which we adjusted for the women's age and parity and their mothers' diabetes.
Altogether 498 of these women aged less than 32 reported gestational diabetes. Prevalence increased with age, from 1.5 per 1000 deliveries for women aged <20 to 4.2 for women aged >30 (odds ratio 2.8; 95% confidence interval 1.9 to 4.3). Parity increased the risk of gestational diabetes; age adjusted odds ratios (95% confidence intervals) for women with two, three, and four or more deliveries compared with one delivery were 1.5 (1.2 to 1.9), 1.9 (1.4 to 2.5), and 3.3 (2.1 to 5.1) respectively.
Women whose mothers had had diabetes during pregnancy were at increased risk of gestational diabetes (table) . The table also shows that there were significant inverse trends in diabetes in relation to birth weight and weight for gestational age (P < 0.001). The increased risks of gestational diabetes were 80%, 60%, and 40% in women whose birth weights were <2500 g, 2500-2999 g, and 3000-3499 g respectively compared with women in the 4000-4500 g group. We observed similar findings in relation to categories of weight for gestational age. Birth weight and weight for gestational age are strongly related; the three highest birthweight categories occur primarily in the three highest categories of weight for gestational age. We therefore limited further analyses of both variables to women whose birth weight was less than 3500 g. The inverse trend in diabetes in relation to weight for gestational age remained significant (table , P < 0.01), but the variation attributed to the truncated range of birth weight was not significant. No other variables examined were associated with diabetes.
Comment
Low birth weight or low weight for gestational age or having a mother who was diabetic during pregnancy Prevalence rates and adjusted odds ratios (95% CI) for self reported gestational diabetes in relation to women's own birth characteristics increases the risk of gestational diabetes. In women who weighed less than 3500 g at birth, weight for gestational age may provide additional predictive information on risk. No other birth characteristics were predictive of gestational diabetes. The non-significant raised risk in women weighing 4500 g or more at birth could indicate undiagnosed or unrecorded maternal diabetes. Low birth weight and low weight for gestational age may be common risk factors for gestational diabetes and non-insulin dependent diabetes. The results are compatible with the fetal origins of disease hypothesis. 5 Future studies combining birth information with risk factors in adulthood may improve predictive models for identifying women at risk of gestational diabetes.
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Competing interests: None declared. Irbesartan was stopped one week after admission and substituted with amlodipine and atenolol. The patient remained jaundiced, with a bilirubin concentration of 324 mol/l after two months. A liver biopsy sample obtained on two different occasions showed notable portal tract expansion with minimal inflammation, ectatic bile ductules, and cholestatic rosettes (figure). These features were more pronounced in the second biopsy sample. Endoscopic retrograde cholangiopancreatography gave normal results. Her condition gradually improved and the bilirubin concentration returned to normal in about 16 weeks. She continues to be anicteric at more than one year's follow up.
The temporal profile of her cholestatic jaundice in relation to the irbesartan and the lack of an alternative cause for liver dysfunction suggests a drug reaction. The diagnosis also fulfils the international consensus criteria for drug induced hepatotoxicity. 1 A review of hepatotoxicity with angiotensin converting enzyme inhibitors showed that a cholestatic pattern was present in the liver of eight out of 13 patients. 2 There have been reports of severe acute hepatic injury as well as 80 reports of minor liver injury in association with losartan. [3] [4] [5] The manufacturers of irbesartan were, however, previously unaware of any association between this drug and severe hepatic dysfunction.
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